Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial☆
To access this article, please choose from the options below
☆ Supported by grants from the NHLBI (RO1-HL 50020 and HL-49970, 1994 to 1999, Bethesda, Md).
PII: S0002-8703(03)00392-2
doi:10.1016/S0002-8703(03)00392-2
© 2003 Mosby, Inc. All rights reserved.
